Skip to main content
Menu
US
US

Resource Center

Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
145 - 153 of 153 Results
Sort by: Best Match
Best Match
Title A-Z
Title Z-A
Filter & Sort
Brochure Icon   Brochure
Get Our Brochure on Luminescence Assay Technology
Get Revvity’s brochure on advanced luminescence assay technology, featuring high sensitivity and dynamic range for gene expression, cell viability, and drug development.
Flyer Icon   Flyer
Download your ATPlite flyer
Revvity offers ATPlite™ and ATPlite 1step assays to measure cellular ATP levels, indicating cell viability and proliferation, using firefly luciferase and D-luciferin. Check out our flyer for the latest solutions in cytotoxicity, cell viability, and cell proliferation assays.
Technical Note Icon   Technical Note
A simple method for preparing GPCR membrane model extracts from stable cell lines for use with the HTRF GTP Gi binding assay
This Technical Note provides a detailed method for preparing GPCR membrane model extracts from stable cell lines for use with the HTRF GTP Gi binding assay, including cell culture preparation, cell lysis, membrane extraction, and assay optimization.
Technical Note Icon   Technical Note
AlphaLISA Acetyl‑Histone H3 lysine 27 (H3K27ac) cellular detection kit
This AlphaLISA immunodetection assay detects alterations in acetylated histone H3 lysine 27 (H3K27ac) levels within cellular extracts.
Application Note Icon   Application Note
Characterizing chemokine receptor inhibitors with AlphaLISA SureFire Ultra, Alpha SureFire Ultra Multiplex and LANCE Ultra cAMP assays
This application note demonstrates how the SureFire Ultra and LANCE Ultra cAMP assays can be used for measuring inhibitors to CCR7 and CXCR2 cell surface receptors using a cellular model system where these receptors are overexpressed in CHO cells.
Whitepaper Icon   Whitepaper
Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases
Traditional treatments for neurodegenerative diseases focus on managing symptoms, but recent advancements in gene therapy offer hope for more effective and sustainable solutions. Read now!
Whitepaper Icon   Whitepaper
Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases
In this white paper, get details about TPD that offers a novel strategy for neurodegenerative diseases by degrading disease-linked proteins, showing promise in preclinical studies.
Technical Note Icon   Technical Note
Introducing AlphaLISA SureFire® Biotin Free: A Versatile Immunoassay Platform for Biotin-Rich Samples.
Featuring homogeneous detection of cell-based proteins, this note shows you how to utilize an innovative system optimized for biotin-rich media while maintaining unmatched assay performance and versatility.
Application Note Icon   Application Note
Comparison of EMT Biomarker Expression in 2D Monolayer and 3D Spheroid Cultures in a Prostate Cancer
This application note shows that AlphaLISA can be used to compare differences in protein expression levels and cellular tolerance for compound treatment between a human prostate cancer cell line grown in monolayers and those same cells grown in 3D spheroids.
resource-center-page-end-card-bg-illuminator.png
resource-center-page-end-card-bg-illuminator-mobile.png

Looking for technical documents?

Find the technical documents you need, ASAP, in our easy-to-search library.